Your browser doesn't support javascript.
loading
Psychometric features of Neuropathic Pain Symptom Inventory in Iranian people with Parkinson's disease.
Taghizadeh, Ghorban; Rodriguez-Blazquez, Carmen; Joghataei, Mohammad Taghi; Goudarzi, Sepideh; Habibi, Sayed Amir Hasan; Bakhsheshi, Merat; Mehdizadeh, Maryam; Fereshtehnejad, Seyed-Mohammad.
Afiliação
  • Taghizadeh G; Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Science, Tehran, Iran.
  • Rodriguez-Blazquez C; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Joghataei MT; Department of Neurosciences, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, 1449614535, Tehran, Iran.
  • Goudarzi S; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Habibi SAH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran.
  • Bakhsheshi M; Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Science, Tehran, Iran.
  • Mehdizadeh M; Department of Occupational Therapy, School of Rehabilitation Sciences, Semnan University of Medical Science, Semnan, Iran.
  • Fereshtehnejad SM; Department of Neurosciences, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, 1449614535, Tehran, Iran. Maryam.mehdizadeh_22@yahoo.com.
Neurol Sci ; 42(8): 3233-3239, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33241536
ABSTRACT

OBJECTIVE:

Neuropathic pain is a type of pain reported in people with Parkinson's disease. There are various scales to evaluate the characteristics of this kind of pain. The purpose of this study was to investigate the psychometric properties of the Neuropathic Pain Symptom Inventory (NPSI), a specific scale that measures neuropathic pain in Iranian people with Parkinson's disease.

METHOD:

Four hundred forty-seven individuals with Parkinson's disease were recruited in the study. Acceptability, internal consistency (Cronbach's alpha), and test-retest reliability (intraclass correlation coefficient, ICC) of NPSI were calculated. Dimensionality was examined through exploratory factor analysis. For convergent validity, correlations of NPSI with Douleur Neuropathic 4, Brief Pain Inventory, King's Pain Parkinson disease Scale, and Visual Analog Scale-Pain were used. Discriminative validity and sensitivity to change between On- and Off- medication states were analyzed.

RESULTS:

A marked floor effect was observed for this scale (64.2%). Cronbach's alpha and ICC were 0.90 and 0.87, respectively. Items of NPSI were placed in 4 factors. A moderate to the strong association (rs = 0.55 to 0.85) between NPSI and other scales was obtained. The results of discriminative validity and sensitivity to change indicate the ability of NPSI to show differences between medication states.

CONCLUSION:

The results of this study suggest that NPSI has acceptable reliability, validity, and sensitivity to change, indicating that this scale is suitable for measuring neuropathic pain in Iranian people with Parkinson's disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Neuralgia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Neuralgia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article